Evidence map›Paper›PMID 42158395›Full record

ReviewFrontiers in microbiology2026

Research progress on the correlation between gut microbiota and the occurrence of hyperuricemia.

Qiaoyi Wang, Li Yan, Yufeng Mo, Yuzhu Dai, Jun Cheng, Minli Qiu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qiaoyi WangDepartment of Clinical Laboratory, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.
Li YanDepartment of Health Economic, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.
Yufeng MoDepartment of Clinical Laboratory, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.
Yuzhu DaiDepartment of Clinical Laboratory, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.
Jun ChengDepartment of Clinical Laboratory, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.
Minli QiuDepartment of Clinical Laboratory, The 903rd Hospital of the Joint Logistic Support Force, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperuricemia is a metabolic disorder caused by excessive uric acid production or reduced uric acid excretion in the body. Approximately 30% of the uric acid in the human body is excreted through the intestines. As a vital component of the intestine, the gut microbiota influences host uric acid levels through multiple mechanisms and pathways, including purine metabolism, short chain fatty acid production, and intestinal barrier function. Additionally, hyperuricemia can also affect the distribution of gut microbiota, and a dysbiosis in this distribution may further trigger inflammation. This paper reviews the correlation between gut microbiota and the occurrence of hyperuricemia, providing a reference for treating hyperuricemia through the gut microbiota.

Indexed as

gut microbiotahyperuricemialipopolysaccharideshort chain fatty acidsuric acid

Identifiers

PMID42158395
PMCPMC13180831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.